A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

NCT00000729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Foscarnet sodium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)